Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring
Faiqa Farrukh1, Deandra Chetram1, Aref Al-Kali1
1Division of Hematolog, Mayo Clinic, Rochester, Minnesota, USA.
American Journal of Hematology
|March 16, 2022
Abstract
No abstract available in PubMed .
More Related Videos
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.9K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.2K
